BEYOND AIRSeptember 23, 2021

FDA 483 - BEYOND AIR - September 23, 2021

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore BEYOND AIR

Record Details

An FDA inspection of BEYOND AIR in Madison, WI, from September 20-23, 2021, revealed that procedures for design validation were not adequately established or implemented. Specifically, the firm's design validation test report for LungFit PH electrode reliability lacked sufficient data to demonstrate that testing units met required continuous NO delivery rates. This indicates a significant issue with the firm's design control processes.

Company: BEYOND AIR
Inspection Date: September 23, 2021
Product Type: Device
Office: Minneapolis District Office
People: Nicholas T. Domer (investigator)
Christina L. Bigham (Investigator )

Open in Dashboard

ID · 4942c91e-a1e8-48bb-9734-3e8e81bcde09